Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Matinas Biopharma Holdings Free Cash Flow 2012-2023 | MTNB

Matinas Biopharma Holdings free cash flow from 2012 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
  
Matinas Biopharma Holdings Annual Free Cash Flow
2023 -15.50
2022 -20.05
2021 -15.48
2020 -17.37
2019 -14.50
2018 -10.86
2017 -12.40
2016 -6.12
2015 -7.89
2014 -8.25
2013 -3.08
2012 -0.06
2011
Matinas Biopharma Holdings Quarterly Free Cash Flow
2023-12-31 -15.50
2023-09-30 -10.92
2023-06-30 -6.48
2023-03-31 -4.09
2022-12-31 -20.05
2022-09-30 -15.71
2022-06-30 -10.49
2022-03-31 -5.30
2021-12-31 -15.48
2021-09-30 -11.49
2021-06-30 -5.52
2021-03-31 -4.65
2020-12-31 -17.37
2020-09-30 -13.07
2020-06-30 -7.84
2020-03-31 -4.67
2019-12-31 -14.50
2019-09-30 -9.60
2019-06-30 -5.45
2019-03-31 -3.04
2018-12-31 -10.86
2018-09-30 -8.24
2018-06-30 -5.33
2018-03-31 -2.91
2017-12-31 -12.40
2017-09-30 -10.37
2017-06-30 -7.55
2017-03-31 -3.03
2016-12-31 -6.12
2016-09-30 -4.00
2016-06-30 -2.64
2016-03-31 -1.54
2015-12-31 -7.89
2015-09-30 -6.75
2015-06-30 -4.58
2015-03-31 -2.33
2014-12-31 -8.25
2014-09-30 -5.83
2014-06-30 -4.19
2014-03-31 -2.28
2013-12-31 -3.08
2013-09-30 -1.35
2013-06-30 -0.44
2013-03-31 -0.15
2012-12-31
2012-09-30 0.01
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.043B $0.001B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.067B 32.15
Chugai Pharmaceutical (CHGCY) Japan $51.455B 23.00
Takeda Pharmaceutical (TAK) Japan $42.377B 8.58
Merck (MKGAF) Germany $22.694B 22.00
Astellas Pharma (ALPMY) Japan $17.735B 28.00
Sandoz Group AG (SDZNY) Switzerland $15.417B 0.00
Neurocrine Biosciences (NBIX) United States $14.290B 39.12
Shionogi (SGIOY) Japan $13.866B 12.05
United Therapeutics (UTHR) United States $12.095B 12.89
Catalent (CTLT) United States $10.064B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.683B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.918B 7.61
Revolution Medicines (RVMD) United States $6.499B 0.00
Ionis Pharmaceuticals (IONS) United States $5.723B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.512B 0.00
Alpine Immune Sciences (ALPN) United States $4.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.982B 0.00
Summit Therapeutics (SMMT) United States $3.152B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 0.00
Corcept Therapeutics (CORT) United States $2.897B 26.25
PTC Therapeutics (PTCT) United States $2.582B 0.00
Dyne Therapeutics (DYN) United States $2.567B 0.00
Indivior (INDV) United States $2.416B 11.45
Recursion Pharmaceuticals (RXRX) United States $2.349B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.109B 12.05
Evotec AG (EVO) Germany $2.009B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.968B 19.15
Fusion Pharmaceuticals (FUSN) Canada $1.832B 0.00
Ardelyx (ARDX) United States $1.827B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.768B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.592B 27.86
Soleno Therapeutics (SLNO) United States $1.511B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.457B 0.00
Pacira BioSciences (PCRX) United States $1.400B 13.31
4D Molecular Therapeutics (FDMT) United States $1.323B 0.00
Xencor (XNCR) United States $1.313B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.313B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.112B 6.65
Cronos Group (CRON) Canada $1.108B 0.00
Cassava Sciences (SAVA) United States $1.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.027B 16.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.994B 0.00
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.913B 14.93
Relay Therapeutics (RLAY) United States $0.902B 0.00
ProKidney (PROK) United States $0.899B 0.00
ARS Pharmaceuticals (SPRY) United States $0.860B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.758B 0.00
Sage Therapeutics (SAGE) United States $0.705B 0.00
Silence Therapeutics (SLN) United Kingdom $0.668B 0.00
Savara (SVRA) United States $0.667B 0.00
Lyell Immunopharma (LYEL) United States $0.665B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.659B 0.00
Altimmune (ALT) United States $0.629B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.555B 7.09
OmniAb (OABI) United States $0.532B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
KalVista Pharmaceuticals (KALV) United States $0.507B 0.00
Bioventus (BVS) United States $0.503B 19.24
Larimar Therapeutics (LRMR) United States $0.502B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.436B 0.00
Organogenesis (ORGO) United States $0.394B 74.25
Tourmaline Bio (TRML) United States $0.391B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.386B 0.00
Nanobiotix S.A (NBTX) France $0.345B 0.00
Fractyl Health (GUTS) United States $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.336B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.283B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Pyxis Oncology (PYXS) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Akebia Therapeutics (AKBA) United States $0.247B 0.00
Foghorn Therapeutics (FHTX) United States $0.225B 0.00
Eliem Therapeutics (ELYM) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Profound Medical (PROF) Canada $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Acrivon Therapeutics (ACRV) United States $0.196B 0.00
Adherex Technologies (FENC) United States $0.191B 232.67
Galectin Therapeutics (GALT) United States $0.189B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.170B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Prelude Therapeutics (PRLD) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
CytoDyn (CYDY) United States $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.158B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.99
OptiNose (OPTN) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.133B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Context Therapeutics (CNTX) United States $0.127B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.27
FibroGen (FGEN) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.20
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Protara Therapeutics (TARA) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Jaguar Animal Health (JAGX) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Talphera (TLPH) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.78